261 271

Cited 4 times in

Endoscopic injection therapy

DC Field Value Language
dc.contributor.author김상운-
dc.contributor.author이용승-
dc.contributor.author한상원-
dc.date.accessioned2018-07-20T07:45:10Z-
dc.date.available2018-07-20T07:45:10Z-
dc.date.issued2017-
dc.identifier.issn2466-0493-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/160488-
dc.description.abstractSince the U.S. Food and Drug Administration approved dextranomer/hyaluronic acid copolymer (Deflux) for the treatment of vesicoureteral reflux, endoscopic injection therapy using Deflux has become a popular alternative to open surgery and continuous antibiotic prophylaxis. Endoscopic correction with Deflux is minimally invasive, well tolerated, and provides cure rates approaching those of open surgery (i.e., approximately 80% in several studies). However, in recent years a less stringent approach to evaluating urinary tract infections (UTIs) and concerns about long-term efficacy and complications associated with endoscopic injection have limited the use of this therapy. In addition, there is little evidence supporting the efficacy of endoscopic injection therapy in preventing UTIs and vesicoureteral reflux-related renal scarring. In this report, we reviewed the current literature regarding endoscopic injection therapy and provided an updated overview of this topic.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Urological Association-
dc.relation.isPartOfINVESTIGATIVE AND CLINICAL UROLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAcrylic Resins/administration & dosage-
dc.subject.MESHChild-
dc.subject.MESHChild, Preschool-
dc.subject.MESHDextrans/administration & dosage*-
dc.subject.MESHDimethylpolysiloxanes/administration & dosage-
dc.subject.MESHEndoscopy/methods-
dc.subject.MESHHumans-
dc.subject.MESHHyaluronic Acid/administration & dosage*-
dc.subject.MESHInfant-
dc.subject.MESHInfant, Newborn-
dc.subject.MESHInjections/methods-
dc.subject.MESHPolytetrafluoroethylene/administration & dosage-
dc.subject.MESHUrinary Tract Infections/etiology-
dc.subject.MESHUrinary Tract Infections/prevention & control*-
dc.subject.MESHUrological Agents/administration & dosage*-
dc.subject.MESHVesico-Ureteral Reflux/complications-
dc.subject.MESHVesico-Ureteral Reflux/therapy*-
dc.titleEndoscopic injection therapy-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Urology-
dc.contributor.googleauthorSang Woon Kim-
dc.contributor.googleauthorYong Seung Lee-
dc.contributor.googleauthorSang Won Han-
dc.identifier.doi10.4111/icu.2017.58.S1.S38-
dc.contributor.localIdA00527-
dc.contributor.localIdA02980-
dc.contributor.localIdA04285-
dc.relation.journalcodeJ01185-
dc.identifier.eissn2466-054X-
dc.identifier.pmid28612059-
dc.subject.keywordEndoscopy-
dc.subject.keywordInjections-
dc.subject.keywordVesicoureteral reflux-
dc.contributor.alternativeNameKim, Sang Woon-
dc.contributor.alternativeNameLee, Yong Seung-
dc.contributor.alternativeNameHan, Sang Won-
dc.contributor.affiliatedAuthorKim, Sang Woon-
dc.contributor.affiliatedAuthorLee, Yong Seung-
dc.contributor.affiliatedAuthorHan, Sang Won-
dc.citation.volume58-
dc.citation.numberSuppl. 1-
dc.citation.startPageS38-
dc.citation.endPageS45-
dc.identifier.bibliographicCitationINVESTIGATIVE AND CLINICAL UROLOGY, Vol.58(Suppl. 1) : S38-S45, 2017-
dc.identifier.rimsid43087-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.